Analysis of COVID-19 Antibodies in Patients Who Have Been Vaccinated With Non-Vaccinated Patients with Confirmed COVID-19 Life
DOI:
https://doi.org/10.31964/mltj.v10i2.607Keywords:
Antibodies, COVID-19, SARS-Cov-2, vaccinesAbstract
COVID-19 immunization is a government initiative to prevent transmission and reduce the incidence of disease and death associated with the SARS-CoV-2 virus. Although the SARS-CoV-2 virus is no longer a significant threat, older adults with comorbidities or people who are immunosuppressed should remain vigilant by maintaining a distance of at least one meter from others, covering their mouths with their elbows when coughing or sneezing, washing their hands regularly, and wearing masks. However, many groups oppose vaccination for various reasons, including the perception that the COVID-19 vaccine is less effective and efficient in preventing SARS-CoV-2 virus infection. This study compared COVID-19 antibody titers in participants who had arrived, without mentioning the vaccine brand, with those who had not yet arrived but had a history of SARS-CoV-2 infection. This study design used a cross-sectional study; the number of samples in the study was 34, the location of this study was the Palembang Public Health Laboratory Center, and the statistical test in the study used the Independent T-test. The study results indicate that the mean antibody titer in the vaccinated group was 98.123. In contrast, in the unvaccinated group, it was 70.641, demonstrating a statistically significant difference with a p-value of 0.000. Further research suggests whether there is a relationship between antibody titers in subjects who have been vaccinated for the second and third time with a history of exposure to the COVID-19 virus.References
Abbas AK, Lichtman AH, Pillai S. (2006). Cellular and Molecular Immunology 6th Ed. Philadelphia, WB Saunders.
Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Sachdeva, R., Gower, C., Ramsay, M., & Lopez Bernal, J. (2022). Effectiveness of COVID-19 Booster Vaccines against COVID-19-Related Symptoms, Hospitalization and Death in England. Nature Medicine, 28(4), 831-837
Apriani, Welin Devsi, and Sinta Ratna Dewi. (2022). Hubungan Antara Tingkat Pengetahuan Dengan Kesediaan Vaksinasi COVID-19 Pada Masyarakat Di Kabupaten Kutai Kartanegara. Jurnal Sains Dan Kesehatan, 4(4), 420–27.
Argista, Z. L. 2021. Persepsi Masyarakat Terhadap Vaksin COVID-19 Di Sumatera Selatan. Fakultas Kesehatan Masyarakat Unıversıtas Srıwıjaya.
Arumsari, Wahyuni, Rani Tiara Desty, Wahyu Eko, and Giri Kusumo. (2021). Gambaran Penerimaan Vaksin COVID-19 Di Kota Semarang. Indonesia Journal of Health Community, 2(1), 35–45.
Bastiana, B., K, D. W., Rachmayanti, N., Koentjoro, M. P., & Surya, P. A. (2022). Sosialisasi Vaksinasi COVID-19 Dan Pemeriksaan IgG Kuantitatif Pre Dan Pasca Vaksinasi Kepada Mahasiswa Magang Di RSI Jemursari Surabaya. Semınar Nasıonal Pengabdıan Kepada Masyarakat 2021.
Budiyanti, Rani Tiyas, Roro Isyawati, and Permata Ganggi. (2023). Analisis Determinan Literasi Terkait Vaksinasi COVID-19 Pada Ibu Di Daerah Pesisir Kota Semarang. Medıa Kesehatan Masyarakat Indonesıa, (July 2021), 94–99.
Damo, N. Y., Porotu’o, J. P., Rambert, G. I., & Rares, F. E. S. (2021). Diagnostik Coronavirus Disease 2019 (COVID-19) Dengan Pemeriksaan Laboratorium Mikrobiologi Klinik. Jurnal E-Biomedik, 9(1)
El-far M, Halwani R, Said E, Trautmann L, Doroudchi M, Jambazian L. (2008). T-Cell Exhaustion in HIV Infection. Cuur HIV//AIDs, 5, 13–19.
Eni Kusyati, Shindi Hapsari, Amrih Widiati, Toet Wuri Prihatin. (2022). Vaksinasi Booster Sebagai Upaya Mempertahankan Tingkat Kekebalan Dan Memperpanjang Masa Perlindungan. Prosiding Seminar Nasional Unımus 5, 2152–59.
Hermiyanti, Emmy. (2018). Biologimolekul Virus. Program Pasca Sarjana Universitas Padjadjaran Bandung, 1–19.
Jabal, K. A., Ben-Amram, H., Beiruti, K., Batheesh, Y., Sussan, C., Zarka, S., & Edelstein, M. (2021). Impact of Age, Ethnicity, Sex and Prior Infection Status on Immunogenicity Following a Single Dose of the BNT162b2 MRNA COVID-19 Vaccine: Real-World Evidence from Healthcare Workers, Israel, December 2020 to January 2021. Eurosurveillance, 26(6), 2100096
Pratama, Tenry Derma, Neno Fitriyani Hasbie, Achmad Farich, and Vera Yulyani. (2022). Analisis Faktor Yang Berhubungan Dengan Kejadian Infeksi COVID-19 Pada Tenaga Kesehatan. Hilistik Jurnal Kesehatan, 16(2), 172–81.
Rotty, I., Kristanto, E. G., Sekeon, S., Ekawardani, N., & Liwe, H. R. (2022). Formation of SARS-CoV-2 Specific Antibody after Vaccination. E-CliniC, 10(1), 16–22
Tuloli, T. S., Abdulkadir, W. S., Aprianto Paneo, M., & Abdullah, N. (2023). Tingkat Pengetahuan Dan Persepsi Masyarakat Tentang Vaksin Covid-19 Studi Kasus : Kota Gorontalo. Indonesian Journal of Pharmaceutical Education, 3(1), 175–185. https://doi.org/10.37311/ijpe.v3i1.18063
Vassilaki, N., Gargalionis, A. N., Bletsa, A., Papamichalopoulos, N., Kontou, E., Gkika, M., Patas, K., Theodoridis, D., Manolis, I., Ioannidis, A., Milona, R. S., Tsirogianni, A., Angelakis, E., & Chatzipanagiotou, S. (2021). Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 Bnt162b2 Mrna Vaccine in Greek Healthcare Workers. Microorganisms, 9(8), 1725
Wang, L., Wang, Y., Ye, D., & Liu, Q. (2020). Review of the 2019 Novel Coronavirus (SARS-CoV-2) Based on Current Evidence. International Journal of Antimicrobial Agents, 55(6),105948
Zhao, Changzhi, Lulu Niu, Xiaoyu Wang, and Wei Sun. (2020). A Simple and Convenient Electrochemiluminescence Immunoassay by Using Gold Nanoparticles as Both Label and Co-Reactant. Bioelectrochemistry, 135,107585. doi: 10.1016/j.bioelechem.2020.107585.
Zheng, Jun. (2020). SARS-CoV-2: An Emerging Coronavirus That Causes a Global Threat. International Journal of Biological Sciences, 16(10), 1678-1685
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mustika Sari H Hutabarat, Agnes Felicia Lubis, Hotman Sinaga
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
